Joint detection method for heart cerebrovascular disease-related protein marker and diagnostic kit thereof

A technology of cardiovascular and cerebrovascular diseases and protein markers, which is applied in the field of liquid phase chip combined with parallel detection method and its diagnostic kit, can solve the problem of poor reproducibility of solid phase biochip technology, limitation of detection throughput, insufficient sensitivity, etc. problems, to achieve high sensitivity, rapid detection, and good stability

Inactive Publication Date: 2012-02-15
MEDI GENETECH
View PDF4 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, these technologies have limitations in detection throughput, cumbersome operation, poor sensitivity, and cannot really meet the needs of clinical dia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Joint detection method for heart cerebrovascular disease-related protein marker and diagnostic kit thereof
  • Joint detection method for heart cerebrovascular disease-related protein marker and diagnostic kit thereof
  • Joint detection method for heart cerebrovascular disease-related protein marker and diagnostic kit thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] Example 1: Liquid-phase chip joint detection method for two kinds of protein markers related to cardiovascular and cerebrovascular diseases

[0049] The specific detection method includes the following steps:

[0050] Select 2 kinds of microspheres numbered 11 and 15

[0051] 1. Activation of desired microspheres

[0052] 1.1 Vortex the microsphere storage solution at full speed for at least 3 minutes to form a uniform microsphere suspension;

[0053] 1.2 Weigh 10 mg of EDC and S-NHS into two centrifuge tubes;

[0054] 1.3 Dissolve in deionized water to make the final concentration 50mg / ml;

[0055] 1.4 Take 1ml of the microsphere suspension and centrifuge at 10000g for 3min, carefully remove the supernatant;

[0056] 1.5 Add 80 μl of activation buffer to resuspend the microspheres;

[0057] 1.6 Add 10 μl of EDC solution (50 mg / ml) and 10 μl of S-NHS solution (50 mg / ml) respectively, mix well, and incubate at room temperature (15-25° C.) in the dark and shake for 2...

Embodiment 2

[0110] Example 2: Liquid-phase chip combined detection method for three kinds of protein markers related to cardiovascular and cerebrovascular diseases

[0111] The specific detection method includes the following steps:

[0112] Select 3 kinds of microspheres numbered 21, 33, and 37

[0113] 1-3 steps are the same as in Example 1.

[0114] 4. Configuration of Antigen Standards

[0115] D-D was prepared according to the concentration of 31250, 6250, 1250, 250, 50, 10, 0ng / ml, PAI-1 and tPA were prepared according to the concentration of 312.5, 62.5, 12.5, 2.5, 0.5, 0.1, 0ng / ml, and the markers The mixtures are labeled as STD6, ​​STD5, STD4, STD3, STD2, STD1, STD0, respectively.

[0116] 5. Preparation of the microsphere mixture (I mixture) coupled with the capture antibody.

[0117] Take the microspheres coated with the capture antibodies of three kinds of cardiovascular and cerebrovascular-related protein markers, as follows: D-D capture antibody microspheres 21, PAI-1 ca...

Embodiment 3

[0144] Example 3: Liquid chip combined detection method for 5 kinds of protein markers related to cardiovascular and cerebrovascular diseases

[0145] The specific detection method includes the following steps:

[0146] Select 5 kinds of microspheres numbered 11, 15, 21, 33, and 37

[0147] 1-3 steps are the same as in Example 1.

[0148] 4. Configuration of Antigen Standards

[0149] D-D is prepared according to the concentration of 31250, 6250, 1250, 250, 50, 10, 0ng / ml, PAI-1, LEP and tPA are prepared according to the concentration of 312.50, 62.50, 12.50, 2.50, 0.50, 0.10, 0ng / ml, ApoB was prepared at concentrations of 31.25, 6.25, 1.25, 0.25, 0.05, 0.01, and 0 mg / ml, and the marker mixtures were labeled as STD6, ​​STD5, STD4, STD3, STD2, STD1, and STD0, respectively.

[0150] 5. Preparation of microsphere mixture (mixture I) coupled with capture antibody

[0151] Take the microspheres coated with capture antibodies of five kinds of protein markers related to cardiovas...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a joint detection method for heart cerebrovascular disease-related protein markers and a diagnostic kit thereof. A joint parallel detection method is characterized in that: a plurality of protein markers of the same sample can be detected at one time, i.e., a quadruple complex consisting of a signal marking detection antibody, a heart cerebrovascular disease-related protein marker, a capture antibody and microspheres is formed by preparing a liquid-phase chip, and the presence and content of various different heart cerebrovascular disease-related protein markers in a sample to be detected are determined by detecting marking signals of different microspheres in the quadruple complex. The invention further discloses constituents of the diagnostic kit and application of the diagnostic kit. The method and the kit provided by the invention have the outstanding advantages of high flux, high sensitivity, high specificity, quick and accurate detection and the like, and can be used for qualitatively and quantitatively detecting a plurality of heart cerebrovascular disease-related protein markers simultaneously.

Description

technical field [0001] The invention relates to an in vitro diagnostic detection method and a diagnostic kit thereof, in particular to a liquid phase chip combined parallel detection method for protein markers related to cardiovascular and cerebrovascular diseases and a diagnostic kit thereof. Background technique [0002] Cardiovascular and cerebrovascular diseases are one of the major diseases and leading causes of death in China's urban population and western developed countries, mainly including cardiovascular diseases represented by coronary heart disease and hypertension, as well as ischemic cerebrovascular diseases and hemorrhagic cerebrovascular diseases sick. Ischemic cerebrovascular disease, also known as acute ischemic cerebrovascular syndrome (AICS), includes cerebral infarction (also known as cerebral infarction, CI) and transient ischemic attack (TIA); hemorrhagic cerebrovascular disease includes Cerebral hemorrhage and subarachnoid hemorrhage. The combined d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N33/68G01N33/532G01N33/533
Inventor 邵棠袁福美陈庆
Owner MEDI GENETECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap